Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Three of four observational studies recently published in Diabetologia suggest an increased risk for cancer associated with use of insulin glargine. However, the authors of these studies cautioned against overinterpretation of their limited data and analyses, which prevented them from reaching definite conclusions. Patients with diabetes should not stop taking their insulin therapy, and patients should consult with their pharmacist if they have concerns about the medications they are taking.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address